2 sources covering

Millions of Americans are not taking their GLP-1 drugs as prescribed

Ars Technica ·

Updated 28m ago

  • Ars Technica changed its headline 28m ago. It first read: “Millions in US use unapproved GLP-1s—and use them in unapproved ways”

Cost and access barriers are pushing people to modified use and unapproved versions.

Read at Ars Technica

Who's covering it

Order

First reported by Fortune at · 2 outlets in all

Filter by type, country or lean
By type
Country
Lean+1 not rated
  1. Ars TechnicaMillions of Americans are not taking their GLP-1 drugs as prescribedCost and access barriers are pushing people to modified use and unapproved versions.
  2. Fortune(subscription required)GLP-1 drugs taken by 30 million Americans now carry an FDA warning for a rare ‘stroke of the eye’ that can cause vision lossThe data on which the FDA’s warning is based suggests a real but low risk of NAION for people taking GLP-1 medications.